 |
|
|||||
|
||||||
        |
||||||
|
 |
|||||
|
|
|
|
|||
|
|
|||||
| Momenta Pharmaceuticals Files for Initial Public Offering | ||||||
| CAMBRIDGE, MA — March 11, 2004 – Momenta Pharmaceuticals, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. All of the shares being offered are to be sold by the Company. The underwriters for this offering will be SG Cowen Securities Corporation and Banc of America Securities LLC acting as joint book-running managers, and CIBC World Markets Corp. and ThinkEquity Partners LLC, acting as co-managers. The number of shares to be offered and the price range for the offering have not yet been determined. The offering will be made only by means of a prospectus. A copy of the preliminary prospectus may be obtained, when available, from either SG Cowen Securities Corporation Prospectus Department, 1221 Avenue of the Americas, 6th Floor, New York, NY 10020; or Banc of America Securities LLC, 9 West 57th Street, New York, NY 10019; or through ADP by fax at (631) 254-7268. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Momenta
|
Press
Contact
|
|||||
|
|
|
||||
|
|
|
|
|||
